Dergiler / Turkish archives of pediatrics (Online) / 2022 / Cilt: 57 - Sayı: 3

Gilbert Syndrome and Genetic Findings in Children: A Tertiary-Center Experience from Turkey

Sayfa
295–299
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We concluded that the c.880_893delinsA (p.Tyr294MetfsTer69) variant, previously shown to be associated with Crigler–Najjar syndrome type I, may also be associated with partial enzyme deficiency leading to the Gilbert syndrome phenotype.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Gilbert syndrome (GS) is a disease characterized by mildly elevated indirect serum bilirubin levels due to mutation in the promoter of the UGT1A1 gene, which causes a decrease in uridine diphosphate glucuronyltransferase enzyme activity.
📊
Temel Bulgular & Veri:This study aimed to evaluate the clinical findings and UGT1A1 mutations of children with Gilbert syndrome.
💡
Sonuç & Katkı:We concluded that the c.880_893delinsA (p.Tyr294MetfsTer69) variant, previously shown to be associated with Crigler–Najjar syndrome type I, may also be associated with partial enzyme deficiency leading to the Gilbert syndrome phenotype.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Gilbert syndrome (GS) is a disease characterized by mildly elevated indirect serum bilirubin levels due to mutation in the promoter of the UGT1A1 gene, which causes a decrease in uridine diphosphate glucuronyltransferase enzyme activity. Gilbert syndrome should be considered based on clinical and laboratory findings in differential diagnosis, which can be supported by genetic analysis. This study aimed to evaluate the clinical findings and UGT1A1 mutations of children with Gilbert syndrome. Materials and Methods: Patients who were admitted to the pediatric gastroenterology clinic and who were considered to have Gilbert syndrome based on clinical and laboratory findings were included in the study. The UGT1A1 analysis was performed by Sanger sequence analysis. Results: A total of 56 children were included in the study. A(TA)7TAA, A(TA)6TAA, and (TA)6/7 allele promoter polymorphism was detected in 75.5%, 22.5%, and 2% of the patients, respectively. Other than these, in 3 patients, 3 different sequence variants associated with GS [c.880_893delinsA (p.Tyr294MetfsTer69) and c.1091C>T(p.Pro365Leu)] were detected. Conclusion: We detected 7 TA repeats in the majority of our patients. A mild bilirubin elevation was determined in cases with 6 repetitions that were not considered risky for Gilbert syndrome. We concluded that the c.880_893delinsA (p.Tyr294MetfsTer69) variant, previously shown to be associated with Crigler–Najjar syndrome type I, may also be associated with partial enzyme deficiency leading to the Gilbert syndrome phenotype.

🔖

Bu Makaleye Atıf Yap

APPAK, Y. Ç., AKSOY, B., ÖZYILMAZ, B., ÖZDEMİR, T. R., BARAN, M. (2022). Gilbert Syndrome and Genetic Findings in Children: A Tertiary-Center Experience from Turkey. Turkish archives of pediatrics (Online), Cilt: 57 - Sayı: 3, 295–299. https://ajindex.com/articles/418271

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Wagner KH, Shiels RG, Lang CA, Seyed Khoei N, Bulmer AC. Diagnostic criteria and contributors to Gilbert’s syndrome. Crit Rev Clin Lab Sci. 2018
  2. 55(2):129-139. [CrossRef] 2. Memon N, Weinberger BI, Hegyi T, Aleksunes LM. Inherited disorders of bilirubin clearance. Pediatr Res. 2016
  3. 79(3):378-386. [CrossRef] 3. Wisnumurti DA, Sribudiani Y, Porsch RM, et al. UGT1A1 genetic variations and haplotype associated with neonatal hyperbilirubinemia in Indonesian population. BioMed Res Int. 2018
  4. 9425843. [CrossRef] 4. Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. N Engl J Med. 1995
  5. 333(18):1171-1175. [CrossRef] 5. Beutler E, Gelbart T, Demina A. Racial variability in the UDP glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci U S A. 1998
  6. 95(14):8170-8174. [CrossRef] 6. McDonagh AF, Palma LA, Schmid R. Reduction of biliverdin and placental transfer of bilirubin and biliverdin in the pregnant guinea pig. Biochem J. 1981
  7. 194(1):273-282. [CrossRef] 7. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000
  8. 15(1):7-12. [CrossRef] 8. Marques SC, Ikediobi ON. The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions. Hum Genomics. 2010
  9. 4(4):238-249. [CrossRef] 9. Vukovic M, Radlovic N, Lekovic Z, et al. UGT1A1 (TA)n promoter genotype: diagnostic and population pharmacogenetic marker in Serbia. Balkan J Med Genet. 2018
  10. 21(1):59-68. [CrossRef] 10. Heydari MR, Fardaei M, Kadivar MR, et al. Prevalence of 2 UGT1A1 gene variations related to Gilbert’s syndrome in south of Iran: an epidemiological, clinical, and genetic study. Iran Red Crescent Med J. 2017
  11. 19(4):e44363. [CrossRef] 11. Sato H, Adachi Y, Koiwai O. The genetic basis of Gilbert’s syndrome. Lancet. 1996
  12. 347(9001):557-558. [CrossRef] 12. Maruo Y, Nishizawa K, Sato H, Doida Y, Shimada M. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics. 1999
  13. 103(6 Pt 1):1224-1227. [CrossRef] 13. Teh LK, Hashim H, Zakaria ZA, Salleh MZ. Polymorphisms of UGT1A1*6, UGT1A1*27 & UGT1A1*28 in three major ethnic groups from Malaysia. Indian J Med Res. 2012
  14. 136(2):249-259. 14. Monaghan G, Ryan M, Seddon R, Hume R, Burchell B. Genetic variation in bilirubin UDP-glucuronosyltransferase